Literature DB >> 10896769

IL-10 deficiency does not inhibit insulitis and accelerates cyclophosphamide-induced diabetes in the nonobese diabetic mouse.

B Balasa1, K Van Gunst, N Jung, J D Katz, N Sarvetnick.   

Abstract

IL-10 exterts profound immunostimulatory and immunoinhibitory effects. To explore the role of IL-10 in autoimmune diabetes of nonobese diabetic (NOD) mice, we generated IL-10-deficient NOD mice. In contrast to our previous results with neutralizing antibodies to IL-10, IL-10-deficient NOD mice developed insulitis and their splenocytes readily responded to islet antigen glutamic acid decarboxylase 65. IL-10-deficient NOD mice did not develop accelerated spontaneous diabetes. On the other hand, IL-10-deficient NOD mice developed accelerated disease following cyclophosphamide (CYP) injection. These findings demonstrate that IL-10 is dispensable for autoimmune diabetes. IL-10's absence fails to accelerate endogenous diabetes but potentiates CYP-induced diabetes. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10896769     DOI: 10.1006/cimm.2000.1658

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  10 in total

Review 1.  The Foxp3+ regulatory T cell: a jack of all trades, master of regulation.

Authors:  Qizhi Tang; Jeffrey A Bluestone
Journal:  Nat Immunol       Date:  2008-03       Impact factor: 25.606

2.  Inhibition of Fas ligand in NOD mice unmasks a protective role for IL-10 against insulitis development.

Authors:  Zuoxiang Xiao; Abdiaziz S Mohamood; Sophia Uddin; Rachel Gutfreund; Chiaki Nakata; Andrew Marshall; Hiroaki Kimura; Patrizio Caturegli; Karl L Womer; Yanfei Huang; Chunfa Jie; Shukti Chakravarti; Jonathan P Schneck; Hideo Yagita; Abdel Rahim A Hamad
Journal:  Am J Pathol       Date:  2011-06-15       Impact factor: 4.307

3.  Diannexin decreases inflammatory cell infiltration into the islet graft, reduces β-cell apoptosis, and improves early graft function.

Authors:  Elaine Y Cheng; Vijay K Sharma; Christina Chang; Ruchuang Ding; Anthony C Allison; David B Leeser; Manikkam Suthanthiran; Hua Yang
Journal:  Transplantation       Date:  2010-10-15       Impact factor: 4.939

Review 4.  Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.

Authors:  Ankit Saxena; Sam Khosraviani; Sanjeev Noel; Divya Mohan; Thomas Donner; Abdel Rahim A Hamad
Journal:  Cytokine       Date:  2014-12-04       Impact factor: 3.861

5.  The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity.

Authors:  A N Theofilopoulos; S Koundouris; D H Kono; B R Lawson
Journal:  Arthritis Res       Date:  2001-02-14

6.  Type-I Interferons Inhibit Interleukin-10 Signaling and Favor Type 1 Diabetes Development in Nonobese Diabetic Mice.

Authors:  Marcos Iglesias; Anirudh Arun; Maria Chicco; Brandon Lam; C Conover Talbot; Vera Ivanova; W P A Lee; Gerald Brandacher; Giorgio Raimondi
Journal:  Front Immunol       Date:  2018-07-16       Impact factor: 7.561

7.  IL-10 Deficiency Accelerates Type 1 Diabetes Development via Modulation of Innate and Adaptive Immune Cells and Gut Microbiota in BDC2.5 NOD Mice.

Authors:  Juan Huang; Qiyuan Tan; Ningwen Tai; James Alexander Pearson; Yangyang Li; Chen Chao; Lucy Zhang; Jian Peng; Yanpeng Xing; Luyao Zhang; Youjia Hu; Zhiguang Zhou; F Susan Wong; Li Wen
Journal:  Front Immunol       Date:  2021-07-30       Impact factor: 7.561

8.  Immunological balance between Treg and Th17 lymphocytes as a key element of type 1 diabetes progression in children.

Authors:  Aleksandra Starosz; Milena Jamiołkowska-Sztabkowska; Barbara Głowińska-Olszewska; Marcin Moniuszko; Artur Bossowski; Kamil Grubczak
Journal:  Front Immunol       Date:  2022-08-24       Impact factor: 8.786

9.  Spleen-derived interleukin-10 downregulates the severity of high-fat diet-induced non-alcoholic fatty pancreas disease.

Authors:  Koro Gotoh; Megumi Inoue; Kentaro Shiraishi; Takayuki Masaki; Seiichi Chiba; Kimihiko Mitsutomi; Takanobu Shimasaki; Hisae Ando; Kansuke Fujiwara; Isao Katsuragi; Tetsuya Kakuma; Masataka Seike; Toshiie Sakata; Hironobu Yoshimatsu
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

Review 10.  Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases.

Authors:  Gu-Jiun Lin; Shing-Hwa Huang; Shyi-Jou Chen; Chih-Hung Wang; Deh-Ming Chang; Huey-Kang Sytwu
Journal:  Int J Mol Sci       Date:  2013-05-31       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.